ESC 25 Guidelines Discussion: Management of Dyslipidaemias

59 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Professor Jeanine Roeters van Lennep (Erasmus Medical Center, NL) to discuss the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.

This focused update delivers the most current, evidence-based recommendations for lipid management and cardiovascular risk reduction. Incorporating new clinical trial data and advances in therapy, the 2025 guidelines provide clinicians with practical strategies for the diagnosis, evaluation and treatment of patients with dyslipidaemia.

In this discussion, Dr Van Spall and Professor Roeters van Lennep highlight the key updates, clinical implications, and take-home messages that matter most for everyday practice.

Recorded remotely from Hamilton and Rotterdam, 2025.

Editors: Jordan Rance and Yazmin Sadik.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David-Ben-Harosh.

Support: This is an independent interview produced by Radcliffe Cardiology.

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook: https://www.facebook.com/RadcliffeCardiology
Follow us on X: https://x.com/radcliffeCARDIO
Categoria
Cardiology
Commenta per primo questo video.

Prossimo